Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Vaccines01:30

Cancer Vaccines

419
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
419
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394
Cancer02:18

Cancer

48.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A quantitative method to compare regional tumor contrast between prone and supine breast MRI.

Frontiers in oncology·2026
Same author

Homocystinuria in a consanguineous indigenous family from rural Honduras: a ten-year follow up and literature review of familial cases.

Archive of clinical cases·2026
Same author

X-SPATIO: An Explanatory Deep Learning Pipeline for the Prediction and Visualization of Spatially Resolved Biomarker Expression in Triple-Negative Breast Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Prone-to-Supine Breast MRI for Tumor Margin Visibility and Surgical Guidance.

Journal of breast imaging·2026
Same author

Invited Commentary.

Journal of the American College of Surgeons·2025
Same author

Exercise That Feels as Good as Possible: Acceptability of an Affect-Based Exercise Prescription Among Stage 0-III Breast Cancer Survivors.

Psycho-oncology·2025

Related Experiment Video

Updated: Jul 23, 2025

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.1K

Breast Cancer Disparities and Innovations: A Focus on Kosovo.

Mary D Chamberlin1, Dafina Ademi Islami2, Richard J Barth3

  • 1Department of Medicine /Hematology-Oncology, Dartmouth College of Medicine and Dartmouth Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

Hematology/Oncology Clinics of North America
|July 13, 2023
PubMed
Summary

Limited mammography screening and outdated surgical methods lead to late breast cancer detection and mastectomy. Combining neoadjuvant chemotherapy, MRI, and surgical mapping can improve breast conservation and patient outcomes.

Keywords:
Breast cancer disparitiesBreast conservationLow- and middle-income countries (LMICs)Surgical innovations

More Related Videos

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.7K

Related Experiment Videos

Last Updated: Jul 23, 2025

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.1K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.7K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiology

Background:

  • Mastectomy remains the primary surgical treatment for breast cancer globally due to limited screening capacity and outdated surgical techniques.
  • Late detection and fear of treatment contribute to poor patient outcomes and limited breast conservation options.
  • There is a critical need for advancements in breast cancer treatment to improve early detection and surgical outcomes.

Purpose of the Study:

  • To explore the combined potential of neoadjuvant chemotherapy, pre-operative breast MRI, and surgical mapping.
  • To identify strategies for increasing breast conservation rates in breast cancer treatment.
  • To reduce patient fear associated with breast cancer treatment and improve overall outcomes.

Main Methods:

  • Review of current breast cancer screening and surgical treatment modalities.
  • Analysis of the role of neoadjuvant chemotherapy in downstaging tumors.
  • Evaluation of pre-operative breast MRI for surgical planning and guidance.
  • Assessment of surgical mapping techniques for precise tumor localization.

Main Results:

  • Neoadjuvant chemotherapy can facilitate tumor shrinkage, making breast conservation more feasible.
  • Pre-operative MRI enhances surgical planning, improving accuracy and reducing positive margins.
  • Surgical mapping techniques aid in precise identification and removal of cancerous tissue.
  • The combination of these methods shows promise for increasing breast conservation rates.

Conclusions:

  • Integrating neoadjuvant chemotherapy, pre-operative breast MRI, and surgical mapping offers a powerful approach to enhance breast cancer treatment.
  • These combined strategies can significantly increase the likelihood of breast-conserving surgery.
  • Adoption of these advanced techniques can alleviate patient fear and lead to improved treatment outcomes.